Results

Total Results: 1,239 records

Showing results for "occurring".

981. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-prevention_research-protocol.pdf
     November 03, 2011 - Occurring in a patient who has had at least five attacks. C.

982. Use of and access to health care by Medicare beneficiaries with diabetes: impact of diabetes type and insulin use, 2007-2011 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-medicare-use_research.pdf
     January 01, 2014 - and conditions related to cardiovascular risk, hypertension, and dyslipidemia, along with other co-occurring

983. Transcript Deliberativemethodswebinar (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/transcript_deliberativemethodswebinar.pdf
     April 19, 2012 - Well, we’re in the process of planning for our very ambitious implementation period that is occurring

984. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
     July 01, 2013 - More nausea and vomiting were reported during liraglutide vs placebo treatments, occurring mainly during

985. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
     October 01, 2011 - rewritten ES-1 to ES-2, p15, p100, Peer Reviewer #7 Executive Summary p. 2 co-occurring; (Ritalin

986. Continuous-Outcomes-Quantitative-Synthesis Methods (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
     March 01, 2011 - Methods Guide for Comparative Effectiveness Reviews Handling Continuous Outcomes in Quantitative Synthesis ii This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare…

987. Ch 9-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_9-user-guide-to-ocer_130129.pdf
     September 21, 2012 - 129 Abstract The feasibility of a study often rests on whether the projected number of accrued patients is adequate to address the scientific aims of the study. Accordingly, a rationale for the planned study size should be provided in observational comparative effectiveness research (CER) study protocols. This chap…

988. Quantitative Synthesis Chapter 3. Choice of Statistical Model for Combining Studies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-3.pdf
     February 01, 2018 - Quantitative Synthesis Chapter 3. Choice of Statistical Model for Combining Studies Quantitative Synthesis Chapter 3. Choice of Statistical Model for Combining Studies Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Systematic Reviews Methods Guide www.ahrq.gov Presenter…

989. Disposition of Comments for Pulmonary Arterial Hypertension: Screening, Management, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
     April 25, 2013 - Disposition of Comments for Pulmonary Arterial Hypertension: Screening, Management, and Treatment Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Pulmonary Arterial Hypertension: Screening, Management, and Treatment Draft review available for public commen…

990. VTE Surveillance Assessment_49_low_SPI (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
     December 01, 2012 - VTE Surveillance Assessment_49_low_SPI     CER # 49:   Comparative effectiveness review of Venous Thromboembolism Prophylaxis in Orthopedic Surgery   Original release date: March 2012 Surveillance Report: December 2012 Key Findings: • Key questions (KQs) 1-4,7-11 are uptodate …

991. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
     September 02, 2016 - Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease Source: www.effectivehealthcare.ahrq.gov Published online: September 2, 2016 Evidence-based Practice Center Methodology Repor t Protocol Project Title: Transparency of Repor ting Requirements Repor t Topic: Omega-3 Fa…

992. Phenylketonuria Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
     February 01, 2012 - 1 Comparative Effectiveness Review Number 56 Adjuvant Treatment for Phenylketonuria (PKU) Executive Summary Background Etiology Phenylketonuria (PKU) is a metabolic disorder in which an inability to properly metabolize the amino acid phenylalanine (Phe) leads to a buildup of Phe in the blood, causing neurot…

993. CARDIOVASCULAR (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - CARDIOVASCULAR AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 03: Cardiovascular Disease Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov …

994. Diabetes-Behavior-Programs Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_research-protocol.pdf
     June 05, 2014 - 1   Evidence-­‐based  Practice Center Systematic Review Protocol Project title: Behavioral Programs for  Diabetes Mellitus I . Background and Objectives for the Systematic Review The high burden of diabetes necessitates careful attention to factors contributing to optimal diabetes care and self-management i…

995. ADHD-Update-protocol-160818 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
     August 18, 2016 - ADHD-Update-protocol-160818 Source: www.effectivehealthcare.ahrq.gov Published online: August 18, 2016 Evidence-based Practice Center Systematic Review Protocol Project Title: Attention Deficit Hyperactivity Disorder (ADHD) Initial publication date if applicable: Nov 25, 2015 Amendment Date(s) if applicabl…

996. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_executive.pdf
     April 01, 2011 - Layout 1 Background Autism spectrum disorders (ASDs) have an estimated prevalence of 1 in 110 children in the United States.1 Disorders within the spectrum include Autistic Disorder, Asperger Syndrome, and Pervasive Developmental Disorder, Not Otherwise Specified (PDD-NOS). Individuals with ASDs have impaired socia…

997. An analytical framework for quantifying components of variability in prescriber decisions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
     April 01, 2010 - algorithms dictating how medications or medical procedures are used. 9 These approaches exploit naturally occurring

998. Disposition of Comments Report for Technical Brief 14 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
     March 18, 2014 - There is a range of lingering and late-occurring effects, and it is possible that this variety is a … As late-occurring effects is one of multiple issues that are important for survivorship care, we do … recurrence/second cancers for which they need to be monitored; b) often experience chronic and late occurring

999. C-Diff-Infections-Surveillance-140925 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
     January 01, 2014 - AHRQ Comparative Effectiveness Review Surveillance Program CER #31: Effectiveness of Early Diagnosis, Prevention, and Treatment of Clostridium difficile Infection Original release date: December 2011 Surveillance Report (1st assessment/cycle 1): October 2012 Surveillance Report (2nd assessment/cycle 2): …

1000. Functional-Limitations-Horizon-Scan-High-Impact-1306 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
      June 01, 2013 - Progressive-relapsing multiple sclerosis (PRMS) is the least common of the four MS disease courses, occurring